As a Drug Use Policy Pharmacist (DUP) at the Cedars-Sinai Medical Network, you will serve as the primary professional staff member in the Department of Pharmacy responsible for the clinical and medication use policies within Cedars-Sinai Medical Care Foundation (CSMCF). The responsibilities cover all aspects of medication use policy analysis, from the development of the new policies to oversight of medications within CS-Link, our Electronic Medical Record system.
Do you want to make a difference in people's lives?
The Drug Use Policy Pharmacist is responsible for the identification, execution, and follow-up on high cost medication usage evaluations and recommendations for the patient population within Cedars-Sinai Medical Care Foundation. The goal of this role is to guide the organization to provide timely, appropriate, and cost-effective drug therapy to our patients. This Drug Use Policy Pharmacist will lead the charge by analyzing pharmaceutical usage and cost trends and work with the appropriate internal parties to develop clinical initiatives focusing on methods to achieve cost reduction around targeted therapies.
This position requires a strong comfort level of data analysis, prior knowledge of high cost drug classes, strong analytical skills and an ability to lead at a cross-functional level by stewarding recommendations forward within various leadership forums, including the Cedars-Sinai Medical Network Physician Leadership, P&T Committee, and other Cedars-Sinai Health System Leadership.
Once targeted therapies are identified, the Drug Use Policy Pharmacist is responsible for putting new policies in place, and educating the staff and physicians on the approach and to ensure that the processes, programs and services are accomplished in a timely and efficient manner. Additionally, providing clinical support and oversight for all utilization management (UM) activities on an ongoing basis, in accordance with CSMCF policies and procedures and in compliance with applicable state and federal regulations, including CMS and/or Medicare Part D and Medi-Cal, as well as accreditation standards such as NCQA.
Analyze pharmacy costs of care, trends, and coordinate the development of appropriate use protocols and guidelines. Prior experience highly desired.
Develop drug product review and recommendations by assessing drug use trends, new drug releases and review of primary literature. Prior experience in drug policy analysis and drug formulary management highly preferred.
Critically evaluate and interpret data from various sources to provide an accurate and balanced response within the guidelines and regulations of industry-based drug information practice.
Set criteria for medication review of non-formulary or non-preferred drug list medications and communicate recommendations.
Research drug information to maintain drug knowledge and disease state understanding. Monitor pipeline medications and new medication research.
Provide support documentation and develop communication for the Pharmacy & Therapeutics (P&T) Committee review process and decisions.
Provide education to physicians, nurses, pharmacists and allied health care professionals regarding safe medication use or changes in medication policy. Triage and respond to drug information inquiries from physicians, pharmacists, nurses and other health care professionals. Some patient correspondence may occur.
Assist with training of pharmacy residents and pharmacy students and with continuing education activities for pharmacy staff, and when appropriate, physicians.
Review drug usage data and make determinations for drug products according to member benefits and coverage criteria.
Assist with budget forecasting and management.
Complete projects related to clinical pharmacy and medication use improvement, as needed.
Assist with implementation and education of new order sets, best practice alerts, updating drug lists, and other work related to medication use within Cedars-Sinai's electronic medical record system, CS-Link (Epic).
Takes a lead role in the implementation of new drug-related initiatives and the establishment of new clinical pharmacy services or initiatives as requested.
With the team, develops and implements clinical criteria for the review of non-formulary or non-preferred medications.
Reviewing and revising scripting for patient and prescriber communication (e.g., criteria, letters) related to drug coverage and other drug utilization programs.
Providing healthcare for more than 100 years, Cedars-Sinai has evolved into one of the most dynamic and highly renowned medical centers in the world. Along with caring for patients, Cedars-Sinai is a hub for biomedical research and a training center for future physicians and other healthcare professionals. This attracts exceptional talent to Cedars-Sinai, including world-renowned physician-scientists who seek a place where they can both conduct research and see patients--the ideal formula for discovery and its translation into cures. Our patients benefit from access to doctors at the top of their fields, and our researchers have an ideal community in which to study the impact of healthcare challenges, and reflect that knowledge in their research. The greater Los Angeles area in which Cedars-Sinai resides possesses unparalleled cultural and ethnic diversity which offers outstanding opportunities for translational and clinical research... and a dynamic environment for medical education.Although community based, Cedars-Sinai is a major teaching hospital affiliated with the David Geffen School of Medicine at the University of California, Los Angeles (UCLA). Cedars-Sinai has highly competitive graduate medical education programs in more than 50 specialty and subspecialty areas, a graduate program in biomedical sciences and translational medicine, a clinical scholars program directed towards junior physicians with aspirations to become clinical scientists, and post graduate training opportunities.There are more than 250 full-time faculty members at Cedars-Sinai. The voluntary medical staff, comprised of more than 2,200 specialty board-certified or board-qualified physicians, represent all of the specialties and subspecialties and collaborate with full-time medical staff in the teaching responsibilities of the graduate medical education programs.